General Intensive Care Unit, Rabin Medical Center, Petah Tikva, Israel.
Crit Care. 2009;13(1):R21. doi: 10.1186/cc7724. Epub 2009 Feb 23.
Tolerance of a spontaneous breathing trial is an evidence-based strategy to predict successful weaning from mechanical ventilation. Some patients may not tolerate the trial because of the respiratory load imposed by the endotracheal tube, so varying levels of respiratory support are widely used during the trial. Automatic tube compensation (ATC), specifically developed to overcome the imposed work of breathing because of artificial airways, appears ideally suited for the weaning process. We further evaluated the use of ATC in this setting.
In a prospective study, patients who had received mechanical ventilation for more than 24 hours and met defined criteria for a weaning trial, underwent a one-hour spontaneous breathing trial with either ATC (n = 87) or pressure support ventilation (PSV; n = 93). Those tolerating the trial were immediately extubated. The primary outcome measure was the ability to maintain spontaneous, unassisted breathing for more than 48 hours after extubation. In addition, we measured the frequency/tidal volume ratio (f/VT) both with (ATC-assisted) and without ATC (unassisted-f/VT) at the start of the breathing trial as a pretrial predictor of extubation outcome.
There were no significant differences in any of the baseline characteristics between the two groups apart from a significantly higher Acute Physiology and Chronic Health Evaluation (APACHE) II score in the ATC group (p = 0.009). In the PSV group, 13 of 93 (14%) patients failed the breathing trial compared with only 6 of 87 (6%) in the ATC group; this observed 8% difference, however, did not reach statistical significance (p = 0.12). The rate of reintubation was not different between the groups (total group = 17.3%; ATC = 18.4% vs. PSV = 12.9%, p = 0.43). The percentage of patients who remained extubated for more than 48 hours was similar in both groups (ATC = 74.7% vs. PSV = 73.1%; p = 0.81). This represented a positive predictive value for PSV of 0.85 and ATC of 0.80 (p = 0.87). Finally, the ATC-assisted f/VT was found to have a significant contribution in predicting successful liberation and extubation compared with the non-significant contribution of the unassisted f/VT (unassisted f/VT, p = 0.19; ATC-assisted f/VT, p = 0.005).
This study confirms the usefulness of ATC during the weaning process, being at least as effective as PSV in predicting successful extubation outcome and significantly improving the predictive value of the f/VT.
Current Controlled Trials ISRCTN16080446.
对自主呼吸试验的耐受性是预测机械通气成功撤机的一项基于证据的策略。由于气管内导管造成的呼吸负荷,一些患者可能无法耐受该试验,因此在试验过程中广泛使用了不同程度的呼吸支持。自动管补偿(ATC)专门开发用于克服人工气道造成的呼吸做功,似乎非常适合撤机过程。我们进一步评估了在这种情况下使用 ATC。
在一项前瞻性研究中,接受机械通气超过 24 小时并符合撤机试验定义标准的患者接受了持续 1 小时的自主呼吸试验,其中 87 例患者接受 ATC(n=87),93 例患者接受压力支持通气(PSV;n=93)。那些能耐受试验的患者立即拔管。主要结局指标是拔管后 48 小时以上仍能维持自主、无辅助呼吸的能力。此外,我们在呼吸试验开始时测量了有(ATC 辅助)和无 ATC(无辅助-f/VT)时的频率/潮气量比(f/VT),作为拔管结局的术前预测指标。
两组之间除急性生理和慢性健康评估(APACHE)II 评分在 ATC 组明显更高(p=0.009)外,无任何基线特征存在显著差异。在 PSV 组,93 例患者中有 13 例(14%)未能通过呼吸试验,而 ATC 组中只有 6 例(6%);然而,观察到的 8%差异未达到统计学意义(p=0.12)。两组之间的再插管率无差异(总组=17.3%;ATC=18.4%vs.PSV=12.9%,p=0.43)。两组中超过 48 小时仍保持拔管的患者比例相似(ATC=74.7%vs.PSV=73.1%;p=0.81)。这代表 PSV 的阳性预测值为 0.85,ATC 为 0.80(p=0.87)。最后,与无辅助 f/VT 的无显著贡献相比,ATC 辅助 f/VT 发现对成功脱机和拔管具有显著贡献(无辅助 f/VT,p=0.19;ATC 辅助 f/VT,p=0.005)。
这项研究证实了 ATC 在撤机过程中的有用性,其在预测成功拔管结局方面至少与 PSV 一样有效,并显著提高了 f/VT 的预测值。
当前对照试验 ISRCTN83222466。